Abstract
The stem bark of Terminalia arjuna (Roxb.) is used by the Ayurvedic physicians in India for the treatment of various cardiovascular diseases, collectively referred to as hritroga. It has been extensively studied in animal models to demonstrate cardioprotective properties, ranging from positive inotropic- , hypolipdemic-, coronary vasodilatory- and antioxidant effects to induction of stress protein in heart. Various bioactive compounds, like triterpinoids, tannins, flavonoids and minerals have been isolated from the stem bark. A number of clinical studies have also reported its beneficial effects in patients of chronic stable angina, endothelial dysfunction, heart failure and even ischemic mitral regurgitation. However, there are some identified lacunae, like standardisation of the ‘drug’, toxicity studies along with pharmacological interactions with other drugs and large multicentre randomized clinical trials, before its use by modern medicine is acceptable.
Keywords: Terminalia arjuna, heart failure, cardiovascular disease, clinical trial, preconditioning, ayurveda, medicinal plants, hritroga, inotropic, hypolipdemic, coronary vasodilatory, antioxidant effects, stress protein, angina, endothelial dysfunction, regurgitation, reserpine, Digoxin, morphine, quinine/quinidine, physostigmine, over the counter (OTC), chronotropic effects, Tetragalloyl glucose, Ellagic acid, Leucocyanidin, superoxide dismutase (SOD), glutathione, catalase (CAT), arjunglucoside, polymorphonuclear cells, echocardiography, hyperlipidemia, hypocholesterolemic, Left ventricular hypertrophy (LVH), LACUNAE, new chemical entity (NCE)
Current Pharmaceutical Biotechnology
Title: Terminalia arjuna in Cardiovascular Diseases: Making the Transition from Traditional to Modern Medicine in India
Volume: 11 Issue: 8
Author(s): S. K. Maulik and C. K. Katiyar
Affiliation:
Keywords: Terminalia arjuna, heart failure, cardiovascular disease, clinical trial, preconditioning, ayurveda, medicinal plants, hritroga, inotropic, hypolipdemic, coronary vasodilatory, antioxidant effects, stress protein, angina, endothelial dysfunction, regurgitation, reserpine, Digoxin, morphine, quinine/quinidine, physostigmine, over the counter (OTC), chronotropic effects, Tetragalloyl glucose, Ellagic acid, Leucocyanidin, superoxide dismutase (SOD), glutathione, catalase (CAT), arjunglucoside, polymorphonuclear cells, echocardiography, hyperlipidemia, hypocholesterolemic, Left ventricular hypertrophy (LVH), LACUNAE, new chemical entity (NCE)
Abstract: The stem bark of Terminalia arjuna (Roxb.) is used by the Ayurvedic physicians in India for the treatment of various cardiovascular diseases, collectively referred to as hritroga. It has been extensively studied in animal models to demonstrate cardioprotective properties, ranging from positive inotropic- , hypolipdemic-, coronary vasodilatory- and antioxidant effects to induction of stress protein in heart. Various bioactive compounds, like triterpinoids, tannins, flavonoids and minerals have been isolated from the stem bark. A number of clinical studies have also reported its beneficial effects in patients of chronic stable angina, endothelial dysfunction, heart failure and even ischemic mitral regurgitation. However, there are some identified lacunae, like standardisation of the ‘drug’, toxicity studies along with pharmacological interactions with other drugs and large multicentre randomized clinical trials, before its use by modern medicine is acceptable.
Export Options
About this article
Cite this article as:
K. Maulik S. and K. Katiyar C., Terminalia arjuna in Cardiovascular Diseases: Making the Transition from Traditional to Modern Medicine in India, Current Pharmaceutical Biotechnology 2010; 11 (8) . https://dx.doi.org/10.2174/138920110793262051
DOI https://dx.doi.org/10.2174/138920110793262051 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
Latest Advancements in Biotherapeutics
The scope of this thematic issue is to comprehensively explore the rapidly evolving landscape of biotherapeutics, emphasizing breakthroughs in precision medicine. Encompassing diverse therapeutic modalities, the issue will delve into the latest developments in monoclonal antibodies, CRISPR/Cas gene editing, CAR-T cell therapies, and innovative drug delivery systems, such as nanoparticle-based ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hyperglycemia and Diabetes Induced by Glucocorticoids in Nondiabetic and Diabetic Patients: Revision of Literature and Personal Considerations
Current Pharmaceutical Biotechnology Oxidative Stress in HIV Patients Receiving Antiretroviral Therapy
Current HIV Research Molecular and Clinical Aspects of the Target Therapy with the Calcimimetic Cinacalcet in the Treatment of Parathyroid Tumors
Current Cancer Drug Targets Current State of Bioabsorbable Polymer-Coated Drug-Eluting Stents
Current Cardiology Reviews Angiotensin-Converting Enzyme Inhibitors in Veterinary Medicine
Current Pharmaceutical Design Oral Inflammation and Bacteremia: Implications for Chronic and Acute Systemic Diseases Involving Major Organs
Cardiovascular & Hematological Disorders-Drug Targets Current Status of Renal Artery Angioplasty and Stenting for Resistant Hypertension: A Case Series and Review of the Literature
Current Hypertension Reviews Targeting of Low-Molecular Weight Drugs to Mammalian Mitochondria
Drug Design Reviews - Online (Discontinued) Crystallization and Preliminary X-Ray Analysis of the Highly Thermostable Sweet Protein Mabinlin II
Protein & Peptide Letters Potentiating the Naturally Occurring Process for Repair of Damaged Heart
Current Pharmaceutical Design Resolving Inflammation in Heart Failure: Novel Protective Lipid Mediators
Current Drug Targets Synthetic and Natural Protease Inhibitors Provide Insights into Parasite Development, Virulence and Pathogenesis
Current Medicinal Chemistry The Potential of Peroxisome Proliferator-Activated Receptor γ (PPARγ) Ligands in the Treatment of Hematological Malignancies
Mini-Reviews in Medicinal Chemistry Dependence of DPPH Radical Scavenging Activity of Dietary Flavonoid Quercetin on Reaction Environment
Mini-Reviews in Medicinal Chemistry Sonic Hedgehog Signaling Activation Promotes Cardioprotective Strategies
Current Signal Transduction Therapy From Amino Acids to Proteins as Targets for Metal-based Drugs
Current Drug Metabolism The Biochemical Mechanisms of T-Cell Anergy
Current Immunology Reviews (Discontinued) Dose-dependent Effects of Esmolol-epinephrine Combination Therapy in Myocardial Ischemia and Reperfusion Injury
Current Pharmaceutical Design Modulation of Staurosporine-Activated Volume-Sensitive Outwardly Rectifying Cl- Channel by PI3K/Akt in Cardiomyocytes
Current Pharmaceutical Design Protein Kinases and Associated Pathways in Pluripotent State and Lineage Differentiation
Current Stem Cell Research & Therapy